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In Vitro Detection of Shiga Toxin Using Porcine Alveolar Macrophages
Abstract
Porcine alveolar macrophages were found to be highly susceptible to the cytolytic effects of a toxin (Shiga
toxin [Stx]) produced by certain strains of Escherichia coli and sometimes associated with clinical disease in
pigs and other animals. In comparison with the cells that are most commonly used for Stx detection and
titration in vitro (namely, Vero cells), porcine alveolar macrophages appeared to be generally more sensitive
and test results could be obtained in less time. Moreover, unlike Vero cells, porcine alveolar macrophages need
not be continuously propagated to ensure immediate availability. They can simply be removed from a low-
temperature repository, thawed, seeded, and shortly thereafter exposed to the sample in question. These
characteristics suggest that porcine alveolar macrophages may be useful in developing a highly sensitive and
timely diagnostic test for Stx.
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In vitro detection of Shiga toxin using porcine alveolar macrophages
William L. Mengeling, Ann C. Vorwald, Nancy A. Cornick, Kelly M. Lager, Harley W. Moon
Abstract. Porcine alveolar macrophages were found to be highly susceptible to the cytolytic effects of a
toxin (Shiga toxin [Stx]) produced by certain strains of Escherichia coli and sometimes associated with clinical
disease in pigs and other animals. In comparison with the cells that are most commonly used for Stx detection
and titration in vitro (namely, Vero cells), porcine alveolar macrophages appeared to be generally more sensitive
and test results could be obtained in less time. Moreover, unlike Vero cells, porcine alveolar macrophages need
not be continuously propagated to ensure immediate availability. They can simply be removed from a low-
temperature repository, thawed, seeded, and shortly thereafter exposed to the sample in question. These char-
acteristics suggest that porcine alveolar macrophages may be useful in developing a highly sensitive and timely
diagnostic test for Stx.
On October 7, 1999, a request was made to assist in de-
termining the cause of illness affecting a group of 3,600
approximately 50-lb pigs. The pigs had recently been moved
several hundred miles from nurseries to grow/finish facilities
comprising 3 separate buildings (1,200 pigs/building) at the
same site. The predominant clinical sign was moderate to
severe, and sometimes fatal, diarrhea. During the acute stage
of the disease, many pigs were also recumbent. Others were
ambulatory but uncoordinated. By the time assistance was
requested, clinical signs had almost subsided, and although
several possible causes were discussed, no further diagnostic
assistance was provided.
On February 1, 2000, a second request was made for di-
agnostic assistance. Another group of approximately 50-lb
pigs at the same site was affected with what was believed
to be the same clinical problem. The following day, samples
were collected from 10 pigs of different pens within the
same building. Pigs in each of the 3 buildings at the site
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were similarly affected, but the group from which samples
were collected had most recently developed clinical signs.
A blood sample, nasal swab, rectal swab, and tonsil swab
were obtained from each of the 10 pigs. Because of the ex-
tensive diarrhea, all pigs were covered with feces and it was
noted during sample collection that every nasal swab, and
to a lesser extent tonsil swabs, had some level of fecal con-
tamination. Each swab was submerged in 2 ml of Earle’s
balanced salt solution supplemented with a high concentra-
tion of antibiotics in a 13- 3 100-mm screw-capped tube.
The type and concentration of antibiotics were as previously
described for maintaining cultures of porcine alveolar mac-
rophages.3 All samples were placed on ice and immediately
taken to the National Animal Disease Center, Ames, Iowa,
for further treatment.
Serum was obtained from each of the blood samples.
Swab contents were dispersed into the surrounding 2 ml of
transport medium by vigorous agitation. Swabs were dis-
carded, an additional 2 ml of transport medium was added
to each tube, and the contents of each tube were filtered
through a 450-mm filter. Aliquots of serum and of the filtered
medium from each swab tube were added to the nutrient
medium of each of 4 types of cell cultures, namely, porcine
alveolar macrophages, established lines of monkey kidney
(MARC-145) and porcine testicle (McClurkin) cells, and fe-
tal porcine kidney cells. In each case, 50 ml of sample was
added to the nutrient medium (1 ml) of a 2 cm2 monolayer
of the appropriate cell type in a 24-well cell culture plate.
Serum was also tested for porcine reproductive and respi-
ratory syndrome virus (PRRSV) by a nested-set polymerase
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Table 1. Isolation of viruses from serum and swab samples collected from pigs believed to be naturally affected with edema disease.
Virus*
Pig number
1 2 3 4 5 6 7 8 9 10
PRRSV
PRCV
PEV
1†
1
1
1
2
1
1
2
1
1
2
1
1
2
1
1
2
2
1
1
1
1
2
1
1
2
1
1
1
2
* PRRSV 5 porcine reproductive and respiratory syndrome virus; PRCV 5 porcine respiratory coronavirus; PEV 5 porcine enterovirus.
No other viruses were identified.
† 1 5 virus identified; 2 5 virus not identified. Viruses were identified by isolation in 1 or more types of cell cultures (see text) except
for identification of PRRSV in 3 pigs (serum) only by PCR.
Table 2. Shiga toxin titer of selected samples.
Sample* Titer†
123
S1191
2R
3R
5R
,1
$2,048
81,920
640
$81,920
4N
5N
2T
3T
10,240
1,280
2,560
1,280
* Samples 123 and S1191 were culture supernatant fluids from
nontoxin (123) and Shiga toxin-producing (S1191) strains of E. coli.
The remaining samples (R 5 rectal, N 5 nasal, T 5 tonsil) were
from pigs (2, 3, 4, or 5) involved in the clinical episode under in-
vestigation.
† Samples 123 and S1191 were tested in 2-fold dilutions from
undiluted to 1:2,048; the remaining samples were tested in 2-fold
dilutions from 1:40 to 81,920.
chain reaction (PCR).8 Three blind passages were made in
MARC-145, porcine testicle, and fetal porcine kidney cells
before a sample was considered virus-free.
Collectively, PRRSV, porcine respiratory coronavirus
(PRCV), and porcine enteroviruses (PEV) were identified by
virus isolation in 1 or more types of cell cultures. More
specifically, PRRSV was isolated in MARC-145 cells from
the serum of 7 pigs, and it was identified by PCR in the sera
of all 10 pigs. Although PRRSV was not identified by cy-
topathic effects in any of the other types of cell cultures, it
was detected in the culture medium of 2 macrophage cul-
tures by adding medium from macrophage cultures to cul-
tures of MARC-145 cells 4 days after the macrophage cul-
tures had been exposed to the field samples. The PRCV and
PEV were isolated from 3 and 8 pigs, respectively. The
PRCV was isolated only from nasal swabs and only in por-
cine testicle cells. The PEV was isolated from rectal swabs
(8 pigs), nasal swabs (5 pigs), and a tonsil swab (1 pig). All
of these 14 swabs were positive in porcine testicle cells,
most were also positive in fetal porcine kidney cells, and a
few were also positive in MARC-145 cells. The identity of
PRRSV and PRCV was confirmed by PCR using specific
primers. Portions of the PRCV genome were also sequenced.
The PRRSV isolates were further characterized by restriction
fragment length polymorphism (RFLP). The RFLP pattern
was 1-4-1 (7 pigs) and 1-3-1 (3 pigs). These RFLP patterns
indicated that the isolates were field strains of PRRSV, i.e.,
not vaccine or vaccine-derived strains.4 The identity of PEV
was confirmed by indirect immunofluorescence with specific
antisera kindly provided by the National Veterinary Services
Laboratories, Ames, Iowa (J. Landgraf). A summary of the
viruses isolated from each of the pigs is presented in Ta-
ble 1.
The isolation of virus from rectal, nasal, and tonsil swabs
in cultures of porcine alveolar macrophages was precluded
because overnight incubation of cultures exposed to these
samples resulted in partial to complete cytolysis. In general,
damage was most severe in cultures exposed to rectal-swab
samples, but cultures were affected regardless of the type of
swab sample. This observation and the knowledge that all
nasal swabs and perhaps all tonsil swabs were contaminated
with feces suggested that porcine alveolar macrophages
might be highly sensitive to some type of enterotoxin.
A cytolytic role for enterotoxin became even more plau-
sible when a probable diagnosis of edema disease was sub-
sequently made at the Iowa State University Veterinary Di-
agnostic Laboratory (ISUVDL) by histologic and bacterio-
logic examination of additional samples submitted from the
same clinical episode. This suggested that the putative toxin
we had identified was a Shiga toxin (Stx) produced by Esch-
erichia coli. If so, it appeared that porcine alveolar macro-
phages might be a highly sensitive cell type for detecting
Stx. A series of steps was taken to test this hypothesis.
The first step was to confirm the identity of the toxin in
the field samples by neutralizing its activity with a bovine
polyclonal antiserum for Stx 1, Stx 2, and Stx 2e.6 Field
samples randomly selected for testing were fluids from 2
rectal swabs, 2 nasal swabs, and 1 tonsil swab. The toxin
preparation used as a positive control was supernatant fluid
from an Stx-positive culture of E. coli, strain S1191.2 Vero
cells were used as the indicator of toxin activity.1 In all cas-
es, the toxic activity was neutralized by the polyclonal an-
tiserum but not by fetal calf sera.
The second step was to determine the titers of toxin in a
representative group of field samples and compare them with
the titer of supernatant fluid from a culture of E. coli strain
S1191. The comparison was done using Vero cells as the
indicator system. The samples selected for comparative testing
and their corresponding Stx titers are presented in Table 2.
The third step was to compare titers of toxic activity de-
termined in porcine alveolar macrophages with those deter-
mined in Vero cells. In this case, culture fluids from E. coli
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Table 3. Comparison of porcine alveolar macrophages and Vero
cells for titration of Shiga toxin (Stx).
Sample* Stx type†
Titer‡
Alveolar
macrophages Vero cells
DH5a
DH5a/pCKS112
DH5a/pJES120
S1191
123
5R
none
Stx 1
Stx 2
Stx 2e
none
unknown
4
1,310,720
10,485,760
10,240
,4
81,920
,4
2,621,440
1,310,720
2,560
,4
40,960
* Sample 5R was fluid from the rectal swab of pig 5; the remaining
samples were culture supernatant fluid from the indicated strain of
E. coli.
† The type of Stx produced by the indicated strain of E. coli; type-
specific antisera were not available to determine the type, or types,
of Stx in sample 5R.
‡ Samples DH5a and 123 were tested in 2-fold dilutions starting
at 1:4; the remaining samples were tested in 2-fold dilutions starting
at 1:160.
strains DH5a (pCKS112)7 (Stx 1), DH5a (pJES120)7 (Stx 2),
and S1191 (Stx 2e) and fluid from the rectal swab of 1 of
the field samples (pig 5) were used in the comparison. Neg-
ative controls were culture fluids from E. coli strain DH5a
and nonpathogenic E. coli strain 123. Alveolar macrophages
were 2-fold to 8-fold more sensitive than Vero cells for de-
termining toxic activity in 3 of the 4 Stx-positive samples
(Table 3). However, there were too few samples to reach a
definitive conclusion in regard to relative sensitivity between
these 2 cell types.
The fourth step was to determine if each of the 3 reference
types of Stx (Stx 1, Stx 2, and Stx 2e) tested in step 3 would
be neutralized with specific antisera (polyclonal antiserum
for Stx 1, Stx 2, and Stx 2e) when porcine alveolar macro-
phages were used as the indicator system. In all cases, the
polyclonal antisera, but not fetal calf serum, neutralized tox-
in activity.
On the basis of diagnostic testing done by others at the
ISUVDL and the identification of Stx in the samples de-
scribed in this report, a primary diagnosis of edema disease
seems appropriate for the clinical episode in question. More-
over, in a retrospective study, genes for Stx 2e, enterotoxins
STa and STb, and F18 fimbria were identified by PCR anal-
ysis of an E. coli strain that had been isolated from the same
clinical episode and kept in the ISUVDL repository (Bos-
worth BT, Casey TA: 1997, Identification of toxin and pilus
genes in porcine Escherichia coli using polymerase chain
reaction [PCR] with multiple primer pairs. Gen Meet Am
Soc Microbiol [abstr. B-509]). From this information, it
seems possible that enterotoxin STa or STb or both caused
the profuse diarrhea observed in most affected pigs. Con-
versely, the concurrent clinical effect, if any, of PRRSV,
PRCV, and PEV is unclear.
There appear to be several attributes of porcine alveolar
macrophages for detecting and titrating Stx. They are highly
sensitive to Stx and may often provide titers of toxic activity
equal to or greater than the commonly used Vero cells. Toxin
can be added as soon as macrophages attach to the culture
surface and nonadherent cells are rinsed away (this process
is typically completed in less than 2 hours, with 1 hour for
attachment and a few minutes to rinse away nonadherent
cells and add fresh medium). Results are obtained in 16
hours or less (there is little or no change in the appearance
of cultures after 16 hours of incubation). This contrasts with
48–72 hours of incubation required for Vero cell assays as
they are commonly performed. Endpoints of toxic activity
are relatively easy to determine because the amount of cy-
tolysis usually changes abruptly. Unlike established cell
lines, porcine alveolar macrophages need not be continuous-
ly propagated to ensure timely availability. They can simply
be removed from a low-temperature repository, thawed,
seeded, and used almost immediately. The toxins produced
by E. coli that are common in ruminants and associated with
foodborne human illness (Stx 1 and Stx 2) as well as the
toxin associated with edema disease (Stx 2e) are all detected.
Although no clear differences were detected in the sen-
sitivity of alveolar macrophages collected from different pigs
during the course of this study (a total of 7 different donors
were used to test this possibility), there is still a chance that
at least subtle differences could be detected among pigs of
different ages and different genetic backgrounds. If so, and
if these in vitro differences reflect the corresponding pig’s
relative susceptibility to the specific enterotoxin-associated
disease, alveolar macrophages might provide a phenotypic
marker in attempting to select for disease resistance. The fact
that alveolar macrophages can be collected relatively easily
from live pigs3 makes this hypothesis both testable and of
potential practical significance.
The sensitivity of porcine alveolar macrophages to Stx
also raises some interesting questions in regard to the path-
ogenesis of edema disease. Selected macrophage populations
of murine peritoneal macrophages and human peripheral
blood monocytes also have been tested for their susceptibil-
ity to Stx.5,8 Although both populations were found to be
resistant to the potential Stx-induced cytolytic effects, they
responded to Stx exposure by producing proinflammatory
cytokines that induced expression of endothelial cell recep-
tors for Stx. It was speculated that this cascade of events
predisposes to Stx-mediated vascular damage.5,7 Whether the
same or a similar phenomenon occurs in edema disease of
swine remains to be determined.
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Detection of bovine herpesvirus-1 in peripheral blood mononuclear
cells eight months postinfection
Pu Wang, David J. Hurley, Lyle J. Braun, Christopher C. L. Chase
Abstract. Peripheral blood mononuclear cells (PBMCs) from 5 calves (3 controls and 2 vaccinates) used
in a bovine herpesvirus 1 (BHV-1) vaccine study with a BHV-1 Cooper strain challenge were collected 6
months after challenge. The PBMCs from the control animals were positive by immunofluorescence for the
BHV-1 glycoprotein D (gD) while the vaccinates were negative. The PBMC samples from 4 of the 5 animals
were examined for BHV-1 DNA by polymerase chain reaction (PCR) and for gD immunofluorescence at 8
months after challenge. The BHV-1 DNA and viral antigen were detected in PBMC samples at 8 months
postinfection, but no virus was isolated.
Bovine herpesvirus-1 (BHV-1), an alphaherpesvirus,15 is
one of the most ubiquitous and important pathogens of cat-
tle. Like other members of the alphaherpesvirus group,13
BHV-1 grows rapidly in cell cultures, infects a wide range
of cell types, and establishes latent infection in neurons of
sensory and autonomic nerve ganglia.2,12 The BHV-1 infec-
tion causes respiratory and reproductive tract diseases.21
Cattle infected with BHV-1 exhibit clinical immunosup-
pression.3,9 Animals with acute BHV-1 infection often de-
velop secondary infection with Manheimmia haemolytica.3
Immune suppression has also been seen in cattle vaccinated
with modified live BHV-1 vaccine, as these animals have
a reduced antibody response to a commercial M. haemo-
lytica leukotoxin vaccine.9 Following acute infection, BHV-
1 antigen and DNA have been detected in spleen, presca-
pular lymph nodes, and peripheral blood mononuclear cells
(PBMCs) through day 19 postinfection.1 Other studies18
have demonstrated BHV-1 antigen in pharyngeal, cervical,
retropharyngeal and inguinal lymph nodes, and tonsil 7
days postinfection. They also demonstrated the presence of
BHV-1 DNA and antigen in CD41 but not CD18 T cells in
the lymph nodes and PBMCs. Recently, BHV-1 latency and
From the Department of Veterinary Science, Box 2175, South
Dakota State University, Brookings, SD 57007 (Wang, Braun, Chase
[corresponding author]), and the Department of Biology and Micro-
biology, Box 2140D, South Dakota State University, Brookings, SD
57007 (Hurley).
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reactivation has been demonstrated in tonsil 60 days post-
infection.19 The BHV-1 has also been detected in PBMCs
of cattle vaccinated with a live BHV-1 gE-negative vaccine
4–5 months postvaccination using PCR.7 In this study,
BHV-1 glycoprotein D (gD) antigen and DNA were de-
tected in PBMCs from calves 6 and 8 months after BHV-
1 infection.
Five yearling beef calves (700–900 lbs) were used in this
experiment. These calves were part of a vaccination-duration
study (9 animals were in the original study). The other 4
animals were sold 4 months after the challenge. Prior to
vaccination, the calves were seronegative (,2) by serum
neutralization to BHV-1, bovine viral diarrhea virus (BVDV)
types 1 and 2, and bovine respiratory syncytial virus. The
animals were also PCR negative for BHV-1 and BVDV. The
vaccinates and control animals were grouped together but
kept in strict isolation throughout the vaccination, challenge,
and postchallenge period. The vaccinated animals were giv-
en 2 doses of a commercial inactivated vaccinea containing
BHV-1, 1 month apart, with the last dose given 8 months
before challenge. All animals were challenged intranasally
with 107 tissue culture infectious dose 50 (TCID50) BHV-1
(Cooper strain, ATCC). Following challenge, BHV-1 virus
was recovered from all calves. The vaccinated calves shed
virus from day 1 to day 6, while the control calves shed
virus day 1 through day 8 and the virus titers were consis-
tently higher in the control group (2–3 log 10). There was
no difference in clinical signs between control and vacci-
 at IOWA STATE UNIV on January 4, 2016vdi.sagepub.comDownloaded from 
